Pykus Therapeutics
Christopher White currently serves as the Chief Business Officer at Pykus Therapeutics, following a successful tenure in similar roles at Ocular Therapeutix, Inc. and various other pharmaceutical firms. With extensive experience in business development, corporate strategy, and innovative product planning, Christopher has held key leadership positions at Silver Creek Pharmaceuticals, Sofregen Medical Inc., Entasis Therapeutics, AMAG Pharmaceuticals, Accenture, A.T. Kearney, Arthur D. Little, and Merck. Christopher holds an MBA in Finance from Columbia Business School and a Bachelor of Science in Chemical Engineering from Tufts University.
This person is not in any teams
Pykus Therapeutics
Pykus Therapeutics, Inc. was founded in 2016 to develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.The co-founders were ophthalmology residents at the Massachusetts Eye and Ear Infirmary and Harvard Medical School when they developed a novel hydrogel to replace the use of intraocular gasduring retinal surgery. This innovation will eliminate the extreme burden placed on patients including the requirement for face-down positioning, inability to see for weeks, and inability to fly for weeks.